Milestone Pharmaceuticals (MIST) Change in Accured Expenses (2018 - 2026)

Milestone Pharmaceuticals' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• Quarterly Change in Accured Expenses fell 58.41% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 78.74% YoY) and the FY2025 annual result came in at $4.4 million, up 406.51% from the prior year.
• Change in Accured Expenses was $1.8 million for Q1 2026 at Milestone Pharmaceuticals, down from $1.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $4.4 million in Q1 2025 and bottomed at -$3.4 million in Q1 2024.
• A 5-year average of $427764.7 and a median of $676000.0 in 2024 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 418.47% in 2024, while the deepest fall reached 10500.0% in 2024.
• Milestone Pharmaceuticals' Change in Accured Expenses stood at -$391000.0 in 2022, then plunged by 131.2% to -$904000.0 in 2023, then soared by 418.47% to $2.9 million in 2024, then sank by 32.41% to $1.9 million in 2025, then retreated by 5.65% to $1.8 million in 2026.
• Business Quant data shows MIST's Change in Accured Expenses at $1.8 million in Q1 2026, $1.9 million in Q4 2025, and $1.3 million in Q3 2025.